bismuth-containing quadruple therapy (PPI + bismuth + metronidazole + tetracycline)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for bismuth-containing quadruple therapy (PPI + bismuth + metronidazole + tetracycline), covering 2024-12-19 to 2024-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of a 14-Day Bismuth-Containing Quadruple Therapy Guided by Drug Susceptibility Testing in Patients with Extremely Refractory Helicobacter Pylori Infection: an Exploratory Study